An interventional study of low calorie diet in Familial Mediterranean Fever (FMF ) and Metabolic Syndrome, sponsored by Cairo University. Recruiting at 1 site in Egypt. Open to participants aged 13 Years to 17 Years. Per ClinicalTrials.gov, last updated 2026-09-22.
Sponsored by Cairo University · Not applicable, Interventional, and Treatment
metabolic syndrome may be prevalent in familial Mediterrean fever. Dietary limitations are main treatment in metabilc syndrome
forty metabolic syndrome participants (adolescents) with familial Mediterrean fever divided equally in to study group received low calorie diet for 3 months and control group who will no change their dietary habits
61 studies on the registry are indexed under Familial Mediterranean Fever; 27 are open to participants now.
This study's planned enrollment of 40 is close to the median of 40 across 27 interventional studies indexed under Familial Mediterranean Fever.
Browse Familial Mediterranean Fever studies →Cairo University is the lead sponsor of 4,941 studies on the registry; 1,458 are open to participants now.
Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
twenty metabolic syndrome participants (adolescents) with familial Mediterrean fever will received low calorie diet for 3 months
Behavioral: low calorie diet
Twenty metabolic syndrome participants (adolescents) with familial Mediterrean fever will no change their dietary habits for 12 weeks
metabolic syndrome participants (adolescents) with familial Mediterrean fever will received low calorie diet for 3 months
fasting blood glcuose
it will be assessed in plasma
Time frame: it will be assessed after 12 weeks
body mass index
it will be assessed while patients were on empty stomach and bladder
Time frame: it will be assessed after 12 weeks
waist circumference
it will be assessed via tape measurement
Time frame: it will be assessed after 12 weeks
high density lipoprotein
it will be assessed in plasma
Time frame: it will be assessed after 12 weeks
triglycerides
it will be assessed in plasma
Time frame: it will be assessed after 12 weeks
systolic blood pressure
it will be assessed from brachial artery
Time frame: it will be assessed after 12 weeks
diastolic blood pressure
it will be assessed from brachial artery
Time frame: it will be assessed after 12 weeks
C reactive protein
it will be assessed in plasma
Time frame: it will be assessed after 12 weeks
Started Aug 2026 (actual). Primary completion is estimated for Dec 2026, 4 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Familial Mediterranean Fever →